Skip to main content
BDX
NYSE Industrial Applications And Services

BD Reports Strong Q2 Results, Raises EPS Guidance, Completes $2B Share Buyback & $2.1B Debt Repayment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$149.5
Mkt Cap
$41.219B
52W Low
$127.536
52W High
$187.35
52W Position info
17% above low
Off High info
20% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BDX sits 17% above its 52-week low of $127.536.

Summary

Becton Dickinson reported solid second-quarter fiscal 2026 financial results, exceeding expectations and raising full-year adjusted EPS guidance, while also executing significant capital return and debt reduction programs.


Key Events · Earnings and Guidance · BDX

  • Q2 Financial Results Exceed Expectations

    Reported second-quarter fiscal 2026 revenue of $4.7 billion (up 5.2% reported, 2.6% FXN) and adjusted diluted EPS of $2.90, both ahead of expectations.

  • Full-Year EPS Guidance Raised

    The company raised its full-year fiscal 2026 adjusted diluted EPS guidance to $12.52-$12.72, up from the previous $12.35-$12.65 range.

  • Significant Capital Return and Debt Reduction

    BD executed a $2.0 billion accelerated share repurchase program and retired $2.1 billion of debt during the quarter, following up on previously announced capital allocation plans.

  • Non-Cash Impairment Leads to GAAP Loss

    GAAP diluted EPS from continuing operations was $(0.13), primarily due to a $450 million non-cash asset impairment charge related to restructuring activities.


Analysis · BDX · Industrial Applications And Services

This 8-K filing details Becton Dickinson's strong second-quarter performance, with revenue and adjusted EPS exceeding expectations. The company's decision to raise its full-year adjusted EPS guidance signals management's increased confidence in future profitability. Critically, the filing confirms the execution of a $2.0 billion accelerated share repurchase program and the retirement of $2.1 billion in debt, demonstrating a significant return of capital to shareholders and a strengthening of the balance sheet following the recent spin-off. While GAAP diluted EPS showed a loss, this was primarily due to a substantial non-cash impairment charge related to restructuring, which is a one-time event aimed at simplifying operations.

At the time of this filing, BDX was trading at $149.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $41.2B. The 52-week trading range was $127.54 to $187.35. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Jun 23, 2026, 6:50 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $140.78
Real-time Price: $164.85 info
Change: +$24.07 (+17%) info
Market Cap: $45.423B info
BDX
May 29, 2026, 8:39 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $148.41
Real-time Price: $164.85 info
Change: +$16.44 (+11%) info
Market Cap: $45.423B info
BDX
May 20, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.95
Real-time Price: $164.85 info
Change: +$17.90 (+12%) info
Market Cap: $45.423B info
BDX
May 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $147.51
Real-time Price: $164.85 info
Change: +$17.34 (+12%) info
Market Cap: $45.423B info
BDX
May 11, 2026, 6:21 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $143.15
Real-time Price: $164.85 info
Change: +$21.70 (+15%) info
Market Cap: $45.423B info